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Introduction
Genomic instability is a hallmark of human cancers, a promi-
nent form of which is chromosomal instability (CIN). CIN is 
most likely caused by errors in mitoses during which the dupli-
cated genome is distributed into two daughter cells. Mitosis is 
composed of several phases: prophase (chromosomes start con-
densing), prometaphase (chromosomes condensed, removal of 
the bulk of sister cohesins, and establishment of bipolar spin-
dles), metaphase (sister chromatids aligned in metaphase plate), 
anaphase/telophase (separation and pulling of sister chroma-
tids), mitotic exit (loss of Cdk1 kinase activity and relaxation of 
the condensed chromosomes), and cytokinesis (end of mitosis 
and the formation of two new daughter cells). Genetic studies in 
yeasts have identified several important mitotic regulators. Key 
among them is the anaphase-promoting complex/cyclosome 
(APC/C), a multisubunit E3 ubiquitin ligase (Morgan, 1999; 
Page and Hieter, 1999). APC/C mediates ubiquitination of pro-
tein substrates including cyclin B1 and securin to drive the pro-
gression of mitosis. It recognizes its substrates through two adapter 
proteins, Cdc20 and Cdh1, which contain similar C-terminal   
substrate-interacting domains composed of seven WD-40 re-
peats (Hendrickson et al., 2001; Pfleger et al., 2001; Schwab   
et al., 2001; Harper et al., 2002; Kraft et al., 2005; Diaz-Martinez 
and Yu, 2007). Destruction boxes or KEN boxes are motifs fre-
quently found in APC/C’s substrates, but other motifs are also 
possible for the recognition (Harper et al., 2002).
Before anaphase, sister chromatids are held together by co-
hesin complexes that resist the pulling force generated by the 
microtubule spindle. It is the dissolution of sister cohesion that 
allows anaphase to happen. The cohesin complexes are com-
posed of protein subunits encoded by Smc1, Smc3, Scc1/Mcd1, 
and Scc3 and are thought to form a ring structure that encloses 
sister chromosomes (Nasmyth, 2005). At the onset of anaphase, 
the Scc1 subunit of the cohesin complex is cleaved by separase, 
a CD clan protease of the caspase family (Uhlmann et al., 2000), 
leading to the opening of the ring and release of sister chroma-
tids. The timing of anaphase is controlled by spindle assembly 
checkpoint (SAC), an elaborate biochemical mechanism that en-
sures that sister chromatids are held together by cohesion rings 
until all of the chromosomes have achieved bivalent spindle 
attachments. By doing that, SAC prevents chromosome missegre-
gation and aneuploidy. Dysfunctional SAC likely underlies the 
CIN phenotype observed in cancer cells.
SAC is activated when the kinetochores are not occupied 
by microtubules or when there is no tension at the kinetochores 
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mutated to alanine. The mutant Cdc20 protein (AAA-Cdc20) 
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cyclin B1. Securin is an inhibitor of separase, and cyclin B1–
Cdk1 kinase can phosphorylate separase (Stemmann et al., 
2001). Phosphorylation of separase opens up the site for the 
binding and inhibition by the Cdk1–cyclin B1 complex (Gorr   
et al., 2005; Boos et al., 2008). Therefore, separase is dually in-
hibited by securin and phosphorylation when the checkpoint is 
activated, preventing premature separation of sister chromatids. 
(Lew and Burke, 2003; Pinsky and Biggins, 2005). A single lag-
ging chromosome is sufficient to activate SAC and cause an ar-
rest  in  metaphase  (Rieder  et  al.,  1995).  The  same  arrest  is 
induced upon treating cells with spindle microtubule-disrupting 
agents such as nocodazole or colcemid. SAC activation (Diaz-
Martinez and Yu, 2007) results in the inhibition of APC–Cdc20 
by Mad2 and BubR1, and thus, the stabilization of securin and 
Figure  1.  Generation  of  Cdc20
AAA  allele. 
(A) A diagram depicting the domain structure 
of Cdc20 protein. (B) Schematic presentation 
of the strategy for the generation of Cdc20
AAA. 
Dashed X’s indicate crossing over in homolo-
gous  recombination.  Green  arrows  indicate 
PCR genotyping primers. Kn, kanamycin-resistant 
gene; TK, thymidine kinase. (C) Southern blot 
analysis of the mutant alleles. (D) PCR geno-
typing of Cdc20
AAA using primers a and b.985 SPINDLE CHECKPOINT AND CANCER • Li et al.
Cdc20
AAA-flox-neo, is likely a null allele caused by the presence 
of the neo cassette (in fact, a truncated protein is expressed 
from the targeted allele; unpublished data). The point mutant 
only becomes active upon Cre-mediated loop out of the neo 
cassette. Thus, the mutation is conditional. We transiently ex-
pressed Cre in one of the targeted clones to activate the mutant 
allele. Sequencing of the Cdc20 cDNA derived from the re-
sulting Cdc20
+/AAA cells demonstrated the expression of the 
mutant allele.
We injected two Cdc20
+/AAA-flox-neo ES clones into mouse 
blastocysts for the production of chimeric mice. Both clones 
gave germline transmission of the AAA-flox-neo allele. Cdc20
+/
AAA-flox-neo mice were crossed to a Cre deleter strain to generate 
Cdc20
+/AAA mice. Fig. 1 C shows a Southern blot analysis of 
AAA-flox-neo and AAA alleles, and Fig. 1 D shows PCR geno-
typing of a litter derived from the Cdc20
+/AAA to Cdc20
+/AAA 
cross. Cdc20
+/AAA mice were healthy and fertile. They did not 
show obvious signs of premature aging. However, intercross-
ing of Cdc20
+/AAA mice failed to produce Cdc20
AAA/AAA mice 
(Table I). Examination of embryos showed that Cdc20
AAA/AAA 
mice could survive up to embryonic day (E) 12.5. The mutant 
embryos were smaller than wild-type controls from early stages 
on (Fig. S1 A). Analysis of apoptosis indicated that the mutants 
suffered massive apoptotic cell death (Fig. S1 B), which likely 
caused the lethality.
The point mutation in Cdc20 causes 
functional loss of SAC
To  determine  the  effect  of  the  mutation  we  introduced  into 
Cdc20 on mitosis at cellular level, we first isolated two indepen-
dent Cdc20
+/AAA clones through transient Cre expression in 
Cdc20
+/AAA-flox-neo ES cells. Western blot analysis indicated that 
the mutation did not interfere with the expression of Cdc20 pro-
tein (Fig. 2 A), although the level in Cdc20
+/AAA-flox-neo cells 
showed a slight decrease, most likely because the AAA-flox-neo 
allele is a null allele. Wild-type and Cdc20
+/AAA ES cells were 
treated with 50 ng/ml nocodazole and harvested at different 
time points for analysis. We found that the mutant cells could 
not arrest in response to spindle microtubule disruption. By 12 h, 
although the majority of the control cells were found in G2/M 
with 4 N DNA content, Cdc20
+/AAA cells continued cell cycle 
and increased their DNA content to >4 N (Fig. 2 B). By 24 h, most 
of the mutant cells had reached an 8-N DNA content. At this 
point, some of the wild-type cells also adapted to the spindle 
checkpoint and entered cell cycle. The continued cycling by the 
mutant cells (and the wild-type cells at a later time point) was 
likely a result of the lack of p53 function in ES cells (Hong and 
These two inhibitory mechanisms are redundant in somatic cell 
lineages (Mei et al., 2001; Huang et al., 2005, 2008), but the 
phosphorylation is uniquely required in mouse embryonic germ 
cells (Huang et al., 2008). Furthermore, the stabilization of cy-
clin B1 prevents other events necessary for mitotic exit, leading 
to cell cycle arrest at prometaphase (Morgan, 1999).
Genetic analyses in budding yeasts have clearly demon-
strated that the SAC is essential in preventing CIN (Li and Murray, 
1991; Yamamoto et al., 1996). The discovery of mutations in 
BUBR1 and BUB1 in a subset of colon cancer cell lines (Cahill 
et al., 1998) suggests a weakened spindle checkpoint as the 
cause of CIN that contributed to the oncogenic process, which 
was further substantiated by the finding that BUBR1 is mutated 
in mosaic variegated aneuploidy, a rare human disorder charac-
terized by increased percentage of aneuploid cells (usually 
>25%) and predisposition to childhood cancers (Hanks et al., 
2004). To determine the role of spindle checkpoint in tumorigen-
esis, a large amount of efforts have gone to the generation and 
analysis of mice with targeted deletions in various SAC compo-
nents. Because the spindle checkpoint is essential in mice, the 
analyses were restricted to heterozygous mice or mice carrying 
hypomorphic alleles. However, despite the compromises in the 
checkpoint, these mice did not display the expected large in-
creases in the rate of spontaneous tumor development (Michel   
et al., 2001; Babu et al., 2003; Baker et al., 2004; Dai et al., 
2004; Iwanaga et al., 2007). Furthermore, these spindle check-
point components may have functions outside the checkpoint, 
and it might be the noncheckpoint-related functions that contrib-
ute to tumorigenesis when disrupted. Thus, whether the SAC is 
an as important tumor-suppressing mechanism as the DNA dam-
age checkpoint is in question.
In this study, we report the generation and analysis of mice 
carrying a mutant Cdc20 allele (Cdc20
AAA) in which the Mad2-
binding sites in Cdc20 were mutated. The mutant Cdc20 protein 
can no longer be inhibited by Mad2 and renders the spindle 
checkpoint dysfunctional. These mice contain a high percentage 
of aneuploid cells and develop spontaneous neoplasms at a much 
increased rate, indicating that the SAC-mediated inhibition of 
Cdc20 is an important tumor-suppressing mechanism. Further-
more, analysis of the mutant cells revealed that the timing of 
anaphase depended on Mad2–Cdc20 interaction, and additional 
expression of BubR1 could not rescue the spindle checkpoint 
defects caused by AAA-Cdc20.
Results
Genetic disruption of Mad2-mediated 
inhibition of Cdc20
The motif for Mad2 binding on Cdc20 (Fig. 1 A) has been 
identified and is homologous to the one used by other Mad2-
interacting proteins such as Mad1 (Zhang and Lees, 2001; Luo 
et al., 2002). We substituted the two charged residues (K129 
and R132) and the proline (P137) within the motif with Ala to 
generate the Cdc20
AAA allele in mice via homologous recom-
bination in mouse embryonic stem (ES) cells. The strategy is 
shown in Fig. 1 B. The targeting construct brought in the mu-
tations along with a floxed neo cassette. The targeted allele, 
Table I.  Intercrosses of Cdc20
+/AAA mice
Age Cdc20
+/+ Cdc20
+/AAA Cdc20
AAA/AAA
Neonate 73 (40.3%) 108 (59.7%) 0 (0%)
E14.5–18.5 12 (40.0%) 18 (60.0%) 0 (0%)
E10.5–12.5 13 (19.7%) 38 (57.6%) 15 (22.7%)
E9.5 8 (19.0%) 22 (52.4%) 12 (28.6%)
E8.5 3 (21.4%) 7 (50.0%) 4 (28.6%)
Numbers on the left indicate number of animals/embryos.JCB • VOLUME 185 • NUMBER 6 • 2009   986
chores were suggested to activate Mad2 and lack of tension was 
proposed to activate BubR1 (Zhou et al., 2002a,b; Logarinho   
et al., 2004). With our AAA-Cdc20 cells, we tested this possibil-
ity experimentally. Cdc20
+/AAA and wild-type ES cells were treated 
with taxol, a microtubule stabilizer that activates SAC by prevent-
ing the dynamics of microtubules and therefore the generation of 
tension. Taxol caused marked increases in mitotic indices over 
time in the control cells but little increases in the mutant cells 
(Fig. 2 E), indicating that Mad2-mediated inhibition of Cdc20 is 
also required for the execution of SAC in response to lack of ten-
sion across kinetochores.
We derived mouse embryonic fibroblasts (MEFs) from 
E12.5 embryos. Cdc20
AAA/AAA MEFs grew noticeably slower than 
the wild-type control even at early passages (<3; Fig. 3 A), and the 
growth succumbed to a complete stop as a result of massive cell 
death as passage number increased (Fig. 3 B). However, the cul-
ture could be rescued with immortalization by the expression of 
SV40 large T antigen, suggesting that the cell death was mediated 
Stambrook, 2004). When the number of mitotic cells was 
counted, we found that the mutant cells did not accumulate in 
mitosis, whereas the control cells did (Fig. 2 C). Moreover, when 
the levels of cyclin B1 and securin were analyzed, we found that 
the mutant cells could not maintain the levels of these two 
mitotic regulators as the wild-type cells in response to the disrup-
tion of microtubules (Fig. 2 D). However, these two proteins did 
accumulate to some extent before being degraded, suggesting 
that there is either residual spindle checkpoint function in the 
mutant cells, that the Chfr-mediated prophase checkpoint was at 
work (Scolnick and Halazonetis, 2000), or both. In agreement 
with the observation that nocodazole treatment did not cause an 
increase in mitotic indices in the mutant cells, there was no ac-
cumulation of phosphorylated histone H3 in the mutants as in 
wild-type cells (Fig. 2 D). These data demonstrate that the muta-
tion we had generated in Cdc20 disrupts SAC and is dominant.
It has been suggested that Mad2 and BubR1 are responsive 
to different kinetochore abnormalities; e.g., unoccupied kineto-
Figure 2.  Cdc20
AAA disrupts SAC. (A) Western blot analysis of Cdc20 expression. (B) FACS profiles of the cells treated with 80 nM nocodazole (noc). 
(C) Mitotic indices of the cells in A. (D) Western blot analysis of the cells treated with nocodazole for various lengths of time. P-H3, phosphorylated histone 3. 
(E) Mitotic indices of the cells treated with 100 ng/ml taxol.987 SPINDLE CHECKPOINT AND CANCER • Li et al.
interact with Mad2, we tested the interaction between Cdc20 
and BubR1 further. The two Cdc20-interacting fragments (Flag 
tagged at the C termini) of BubR1 were transiently expressed in 
iMEFs and immunoprecipitated with anti-Flag antibodies. Copre-
cipitated Cdc20 protein was detected with Western blotting. 
As shown in Fig. 4 B (1–477), BubR1 could not interact with 
AAA-Cdc20, whereas 490–679 BubR1 could, supporting the 
notion that the binding of the N terminus of BubR1 to Cdc20 re-
quires Mad2–Cdc20 interaction. However, the mutant Cdc20 bound 
490–679 BubR1 much less efficiently than wild-type Cdc20 
(Fig. 4 B), suggesting that Mad2–Cdc20 interaction also plays a role 
in promoting the binding of BubR1’s C-terminal part to Cdc20.
Next, we tested whether overexpression of BubR1 could 
compensate for the lost interaction between Mad2 and Cdc20 
in the mutant cells. Empty vector or BubR1-expressing vector 
together with a GFP-expressing plasmid were transfected into 
iMEFs. Mitotic indices of the transfected (GFP positive) cells were 
determined before and after 12-h nocodazole treatment. Although 
additional expression of BubR1 (Fig. 4 C) significantly increased 
the mitotic indices of wild-type cells even in the asynchronously 
growing population, it had little impact on the homozygous mutant 
cells either treated with nocodazole or untreated (Fig. 4 D), sug-
gesting that the inhibition of Cdc20 by BubR1 requires the func-
tion of Mad2. In fact, the endogenous level of BubR1 was already 
noticeably elevated in Cdc20
AAA/AAA cells (Fig. 4, A and C), but the 
SAC was still ineffective. It is unclear at the moment what causes 
the elevation in BubR1 levels in AAA-Cdc20 homozygous cells. 
by the p53, Rb, or both pathways. When immortalized MEFs 
(iMEFs) were treated with nocodazole, wild-type cells accumu-
lated in mitosis, but Cdc20
AAA/AAA cells failed to do so (Fig. 3 C), 
indicating that the mutation disrupts SAC in MEFs as well. Similar 
to the ES cells, Cdc20
AAA/AAA iMEFs did not respond to taxol treat-
ment (Fig. 3 D). Cdc20
+/AAA iMEFs displayed a milder defect in the 
checkpoint function than the homozygous mutant cells (Fig. 3 C).
To demonstrate that the mutation abolishes the interaction 
between Cdc20 and Mad2, we treated the iMEFs with nocodazole 
(to activate the spindle checkpoint) and MG132 (to prevent the 
mutant cells from leaving mitosis). Cdc20 was immunoprecipi-
tated, and Western blotting was performed to determine whether 
Mad2 was in the immune complexes. As shown in Fig. 4 A, al-
though Mad2 was clearly present in the immunoprecipitation 
from wild-type cell lysates, it was absent from the mutant, dem-
onstrating that the mutation we generated indeed disrupted the 
interaction between Cdc20 and Mad2. However, BubR1 could 
still interact with the mutant Cdc20, albeit less efficiently, sug-
gesting that the interaction between BubR1 and Cdc20 does not 
strictly depend on Mad2–Cdc20 interaction.
A recent study demonstrated the presence of two Cdc20-
interacting motifs in BubR1 (Davenport et al., 2006). One motif 
is located at the N terminus (aa 1–477) and the other in the mid-
dle (aa 490–679) of BubR1. It was suggested that the N-terminal 
motif bound Cdc20 in a Mad2-dependent manner, whereas the 
C-terminal motif bound in a Mad2-independent fashion. With 
the availability of cells expressing mutant Cdc20 that could not 
Figure 3.  Analysis of Cdc20
AAA/AAA MEFs. (A) Growth curve analysis. (B) Population doubling (PDL) analysis under the 3T9 protocol. (C) Mitotic indices of 
the iMEFs treated with 100 nM nocodazole. (D) Mitotic indices of the iMEFs treated with 100 ng/ml taxol. Error bars indicate SD.JCB • VOLUME 185 • NUMBER 6 • 2009   988
as early as passage 3, both heterozygous and homozygous mutant 
MEFs showed high percentages of cells with abnormal karyotypes, 
reaching 28% and 52%, respectively, whereas the wild-type cells 
only showed 5% aneuploidy (Fig. 5 C).
The abnormal mitoses in the mutant cells also suggested 
that anaphases began prematurely in the mutant. To demonstrate 
that, we marked the chromosomes of the cells with H2B-GFP 
carried on a retroviral vector. Unperturbed mitoses starting from 
nuclear envelop breakdown were recorded with a live cell imag-
ing system. As shown in Fig. 6 A, the mutant cell entered ana-
phase much quicker than the wild type. 30 mitoses were analyzed, 
and the result is shown in Fig. 6 B. On average, the mutant entered 
anaphase 8–10 min earlier than the control (Fig. 6 B), indicat-
ing that Mad2-mediated inhibition of Cdc20 is critical in the tim-
ing of anaphase. In agreement with the advancement of anaphase 
in mutant cells, Cdc20
AAA/AAA MEFs contained reduced levels of 
securin and cyclin B1 (Fig. S2).
In the heterozygous cells, additional BubR1 expression was able 
to improve the checkpoint function to some extent (Fig. 4 D), most 
likely working through the wild-type Cdc20 protein.
Abnormal mitoses in MEFs  
harboring Cdc20
AAA
During normal mitotic divisions, SAC is essential in delaying ana-
phase until all sister chromatids are aligned at metaphase plate. We 
analyzed mitoses in asynchronously growing MEFs undisturbed 
by microtubule-disrupting agents. Microscopic observation indi-
cated that the mitoses were highly abnormal in the mutants (Fig. 5, 
A and B). In metaphase (when a metaphase plate was clearly visi-
ble), the chromosomes in mutant cells were misaligned (Fig. 5 A), 
and in anaphase, there were lagging chromosomes or chromosome 
bridges in the mutant cells (Fig. 5 A). Quantitation of the abnormal 
mitoses are shown in Fig. 5 B. The abnormal mitoses in the mutant 
MEFs suggested that these cells should become aneuploid. Indeed, 
Figure 4.  The interaction between BubR1 and AAA-Cdc20. (A) Coimmunoprecipitation analysis of the interaction between Mad2 and Cdc20. Cdc20 
was immunoprecipitated from nocodazole- and MG132-treated (8 h) iMEF cells, and the immune complexes were analyzed with Western blotting. Note 
that Cdc20 was immunoprecipitated with mouse monoclonal antibodies and detected with rabbit polyclonal antibodies. IB, immunoblotting. (B) The two 
Cdc20-binding domains of BubR1 interact with AAA-Cdc20 differentially. Flag-tagged BubR1 (1–477) or BubR1 (490–679) was transiently expressed in 
iMEFs from which Cdc20 was immunoprecipitated. The immune complexes were analyzed with Western blotting. Note that the same mouse monoclonal 
anti-Cdc20 antibodies were used for immunoprecipitation (IP) and Western blotting. (C) Exogenous expression of BubR1 in iMEFs. (D) Mitotic index analysis 
of iMEFs transfected with a BubR1-expressing plasmid. The asterisk indicates statistical significance (P < 0.05). Error bars indicate SD.989 SPINDLE CHECKPOINT AND CANCER • Li et al.
wild-type and mutant mice were significantly different with P < 
0.0001. Among 29 tumor samples analyzed histopathologically, 
four were hepatomas (13.8%) and the rest were lymphomas. Spec-
trum karyotyping (SKY) analysis of one lymphoma sample dem-
onstrated aneuploidy (2 N + 3) in this tumor (Fig. 7 D). The tumors 
developed in wild-type animals were all lymphomas.
Discussion
Cancer is thought to be caused by multistep genetic changes that 
had started in a single cell. Epidemiological and genetic analy-
ses have led to an estimation of the number of mutations needed 
for  malignant  transformation  to  be  about  six  (Armitage  and 
Doll, 1954, 2004; Kinzler and Vogelstein, 1996). Given the mu-
tation rate in humans, it is extremely rare for a single cell to ac-
quire all the necessary mutations. Thus, it has been postulated 
that destabilizing the genome is necessary for cancer develop-
ment. A prominent form of genetic instability in cancer is chromo-
somal. CIN can be gains or losses of whole chromosomes or 
translocation of chromosome segments. Alterations in chromo-
some number or aneuploidy are found in nearly all major human 
Chromosome instability and spontaneous 
tumorigenesis in Cdc20
+/AAA mice
To  determine  whether  the  increased  aneuploidy  in  the  mutant 
MEFs was also true in adult mice, we karyotyped splenocytes iso-
lated from 5-mo-old wild-type and Cdc20
+/AAA mice (three animals 
per genotype). The isolated cells were cultured for 48 h and en-
riched for mitotic fraction with nocodazole and MG132 treatment 
and processed for chromosome spreading. As shown in Fig. 7 A, 
Cdc20
+/AAA splenocytes contained 35% aneuploid cells, whereas 
the wild type contained only 6%. To determine whether such a high 
percentage of aneuploidy has any impact on spontaneous tumori-
genesis, we subjected cohorts of wild-type and Cdc20
+/AAA mice to 
long-term (24 mo) observation of tumor development. These mice 
were under a mixed genetic background of C57BL/6 and 129SV. 
As shown in Fig. 7 B, Cdc20
+/AAA mice had a significantly in-
creased rate of tumor formation. Palpable tumors could be detected 
as early as 6.8 mo in the mutant mice. By 24 mo, 50% of the mutant 
mice developed tumors, whereas only 10% of the wild-type ani-
mals did. 38% of the mice that had tumors developed tumors at 
multiple organ sites. Fig. 7 C shows a couple of large images of   
the tumors. Logrank test indicated that the tumor-free curves of 
Figure 5.  Aberrant mitoses and aneuploidy in the mutant MEFs. (A) Representative images of mitotic cells. DNA was visualized with DAPI staining. 
The arrowhead indicates a DNA mass drifted far away from the bulk, and the arrow indicates anaphase bridges. (B) Quantitation of abnormal mitoses.   
(C) Karyotype analysis is shown. Error bars indicate SD.JCB • VOLUME 185 • NUMBER 6 • 2009   990
et al., 2004). Although Mad2-deficient cells are nonviable   
(Michel et al., 2001), the nonviability could be rescued with the 
deletion of p53 (Burds et al., 2005). Thus, a complete lack of 
SAC function does not cause cell lethality by itself. Rather, the 
cells are eliminated by other protecting mechanisms such as 
p53-induced apoptosis, perhaps because of the severe aneuploid 
nature of these cells. However, the SAC is not “all or none.” It can 
be compromised to certain degrees as indicated by the fact that 
the mice heterozygous for the essential components are viable 
despite clear defects in the checkpoint; e.g., not only do the cells 
derived from these mice arrest less efficiently than wild-type cells 
in response to microtubule disruption, there were also certain per-
centages of aneuploid cells present in the adult animals. The per-
centage of the aneuploid cells could be tolerated as high as >30% 
(BubR1 hypomorphic mice and our AAA-Cdc20 heterozygous 
mice). It is unclear at present whether such a high percentage of 
aneuploidy has any impact on normal physiology of the animals.
Despite the aneuploidy displayed by SAC mutants, only 
small increases in cancer susceptibility have been reported. 
For example, tumor incidence was increased (to 6%) in mice 
tumor types (Mertens et al., 1994). Examples include the loss of 
chromosome 10 in glioblastomas, often reflecting the inactiva-
tion of the tumor suppressor gene PTEN (phosphatase and ten-
sin homologue; Wang et al., 1997) and the gain of chromosome 7 
in papillary renal carcinomas, reflecting a duplication of a mu-
tant Met oncogene (Zhuang et al., 1998). However, most of the 
time, no specific molecular advantages can be associated with a 
particular gain or loss of a chromosome. In fact, cancer cells 
display gross abnormalities in their chromosome numbers, most 
likely as a result of defects in the quality control of sister chro-
matid separation, including defects in the SAC (for reviews see 
Chi and Jeang, 2007; Ganem et al., 2007; Weaver and Cleveland, 
2007; Storchova and Kuffer, 2008).
A complete lack of SAC is incompatible with viability in 
higher eukaryotes. Mad2-deficient mice show early embryonic 
lethality around the blastocyst stage (Dobles et al., 2000). Loss of 
Mad2 in Caenorhabditis elegans is also incompatible with the vi-
ability (Kitagawa and Rose, 1999). Other central components of 
the SAC, Bub1, BubR1, and Mad1, are all essential as well (Basu 
et al., 1999; Kitagawa and Rose, 1999; Babu et al., 2003; Wang   
Figure 6.  Advanced timing of anaphase in mutant MEFs. (A) Clips from time-lapse video recordings. The arrow indicates lagging chromosomes.   
(B) Quantitation of the timing of anaphase onset given in minutes. Error bars indicate SD.991 SPINDLE CHECKPOINT AND CANCER • Li et al.
incidence (Weaver et al., 2007). Thus, the rate of aneuploidy can-
not be the only determinant on the likelihood of tumorigenesis in 
SAC mutants. Another possibility is that Cdc20 and Bub1 may 
have functions outside mitosis. Loss (in the case of Bub1) or gain 
(in the case of AAA-Cdc20) of these functions in combination 
with aneuploidy may therefore drive the robust tumor develop-
ment in these mice and potentially explain the difference in the 
tumor spectra between these two strains. Indeed, Cdc20 was sug-
gested to function in regulating gene expression in mammalian 
cells (Yoon et al., 2004), and budding yeast CDC20 was found to 
be able to override G2/M DNA damage checkpoint when over-
expressed (Lim and Surana, 1996) and needs to be repressed in 
S phase to prevent premature mitotic entry (Clarke et al., 2003). 
Given the fact that AAA-Cdc20 is no longer inhibited by Mad2, 
this mutant Cdc20 protein might have gained additional func-
tions that help oncogenic transformation. In the case of Bub1, it 
seems to be required for the induction of cell death when chromo-
some missegregates (Jeganathan et al., 2007) and may have other 
unspecified functions that prevent tumorigenesis.
Both Mad2 and BubR1 can bind to Cdc20 directly. The 
Mad2-binding sites in Cdc20 are conserved in other Mad2-
interacting proteins such as Mad1 (Zhang and Lees, 2001; Luo   
et al., 2002). However, the BubR1-interacting domain in Cdc20 
remains ill defined (Luo et al., 2002). Recent studies in budding 
yeasts suggested that MAD3 (BubR1 in mammals) uses its 
KEN box to interact with CDC20 and inhibits APC
Cdc20 as a 
pseudosubstrate (Burton and Solomon, 2007), and it seems that 
a similar mechanism is used by BubR1 in mammals (Malureanu 
et al., 2009). One possibility for why both Mad2 and BubR1 are 
essential SAC components is stoichiometry. In other words, the 
number of Mad2 or BubR1 molecules is perhaps by themselves 
with severely reduced BubR1 levels (Baker et al., 2004). Also, 
28% of mice heterozygous for Mad2 develop small, self-limiting, 
late onset (18–19 mo) papillary lung adenocarcinomas (Michel   
et al., 2001), and mice heterozygous for functional BubR1 or 
Bub3 are more prone to the development of colorectal (Dai   
et al., 2004) or lung (Babu et al., 2003; Dai et al., 2004) tumors 
after treatment with azoxymethane or DMBA (9,10-dimethyl-
1,2-benzanthracene), respectively. More recently, mice hetero-
zygous for Mad1 were reported to display a small increase (from 
9 to 19%) in the incidence of spontaneous tumors at old ages 
(Iwanaga et al., 2007), and mice heterozygous for centromere 
protein E similarly displayed a small increase in tumor incidence 
(Weaver et al., 2007). These minor tumor phenotypes put the sig-
nificance of the SAC in preventing the tumorigenesis in question. 
However, results from Cdc20
+/AAA (this study) and Bub1-deficient 
mice (Jeganathan et al., 2007) suggest that the loss of SAC func-
tion can be highly tumorigenic. What could be the reason for 
the differences in the rates of tumor development among various 
mouse strains with SAC defects? One obvious possibility is 
the severity of the checkpoint defects and thus the rates of 
aneuploidy. Indeed, both Cdc20
+/AAA and Bub1 hypomorphic mice 
contain  high  percentages  of  aneuploid  cells  (>30%  when 
splenocytes were analyzed). However, mice deficient in BubR1 or 
doubly heterozygous for Bub3 and Rae1 contain a similarly high 
percentage of aneuploid cells, and yet, these mice are not tumor 
prone (Baker et al., 2004, 2006). One might argue that the pre-
mature aging process in BubR1-deficient and Bub3
+/ Rae1
+/ 
mice prevented these animals from developing tumors. However, 
such an argument could not be applied to centromere protein E
+/ 
mice, which also display similarly high percentages of aneuploid 
cells as Cdc20
+/AAA mice but only have a mild increase in tumor 
Figure 7.  Spontaneous tumorigenesis in Cdc20
+/AAA mice. (A) Karyotype analysis of the splenocytes. (B) Tumor-free survival analysis of wild-type and 
Cdc20
+/AAA mice. (C) Large images of tumors. (D) SKY analysis of one lymphoma.JCB • VOLUME 185 • NUMBER 6 • 2009   992
were precipitated with protein G agarose beads (GE Healthcare), washed 
four times with NETN buffer, and eluted with 2× SDS loading buffer. The 
eluted proteins were separated by SDS-PAGE and probed with antibodies 
against Cdc20, BurbR1, and Mad2 (Santa Cruz Biotechnology, Inc.).
Karyotype analysis
To isolate splenocytes, spleens were collected and minced between two 
microscope slides. The released the cells were cultured for 48 h in RPMI 
1640 supplemented with 10% FBS, 5 µg/ml lipopolysaccharide, 1 µg/ml 
anti–mouse CD28, and 1 µg/ml anti–mouse CD3e (BD).
To prepare chromosome spreads, MEFs (at passage 3) and spleno-
cytes were treated with 10 µM MG132 (Calchemico) for 5 h at 37°C, har-
vested  and  resuspended  in  5  ml  0.075  M  KCl,  and  incubated  in  the 
hypotonic solution at 37°C for 10 min. The cells were fixed in Carnoy’s so-
lution (methanol/acetic acid [3:1]), washed with PBS, and resuspended in 
0.5 ml Carnoy’s solution. The cell suspension was dropped onto prewetted 
microscope slides and air dried. Chromosomes were visualized by 10-min 
staining in 5% Giemsa solution.
For SKY, lymphoma cells were isolated and cultured. Chromosome 
spreads were prepared from asynchronously growing population of cells and 
stained with chromosome-specific probes in our cytogenetic core laboratory.
Histology analysis
Embryos or tumor tissues were fixed overnight in 4% PFA/PBS, pH 7.4, 
and embedded in paraffin. 4-mm sections were prepared and stained with 
hematoxylin and eosin according to standard protocols. For immunostain-
ing of activated caspase 3, tissue sections were boiled for 10 min in citrate 
buffer (10 mM sodium citrate and 0.05% Tween 20, pH 6.0) in a micro-
wave oven to retrieve antigens and were stained with antiactive caspase 3 
antibodies (Cell Signaling Technology).
Imaging
For regular fluorescence imaging, we used a microscope (E800; Nikon) 
with a Plan Fluor 100×/1.30 oil objective (Nikon). Images were captured 
with a digital camera (SPOT-RT model 2.3.1; Diagnostic Instruments, Inc.). 
Fluochromes used are DAPI, Texas red, and FITC. For live imaging of YFP-
labeled cells, we used a microscope (Axiovert 200; Carl Zeiss, Inc.) with 
a Plan Fluor 20×/0.30 objective (Carl Zeiss, Inc.). Images were taken with 
a digital camera (AxioCam; Carl Zeiss, Inc.).
Online supplemental material
Fig. S1 shows the embryonic phenotype of Cdc20
AAA/AAA mice, and Fig. S2 
shows immunostaining of securin and cyclin B1 in the mutant MEF cells in 
mitosis.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.200904020/DC1.
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insufficient to inhibit all APC
Cdc20 complexes. However, our results 
(Fig. 4 E) indicate that this is unlikely the case. It is more likely that 
the mitotic checkpoint complex (MCC) containing Mad2, BubR1, 
Bub3, and Cdc20 blocks the E3 activity of APC
Cdc20 (Sudakin et al., 
2001) instead of Mad2 and BubR1 acting separately. Indeed, MCC 
was much more potent in inhibiting APC
Cdc20 than Mad2 alone or 
BubR1 in complex with Bub3 (Sudakin et al., 2001), suggesting a 
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that could not be detected with coimmunoprecipitation.
Materials and methods
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